Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2013-12-09 Regulatory Filings
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings
2013-12-09 English
Regulatory Filings 2013
Regulatory Filings
2013-12-02 English
PRIMARY DOCUMENT
Director's Dealing
2013-11-22 English
FORM S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes details about the types of securities to be offered (common stock, preferred stock, debt securities, warrants), the maximum aggregate offering price, and the terms of the offering. This is a capital raising document, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement for securities issuance. Therefore, it fits the category of Capital/Financing Update filings.
2013-11-18 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the securities being offered, risk factors, use of proceeds, selling stockholder, and other disclosures typical of a registration statement. This is not an annual report, earnings release, or any other financial report but a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high given the clear identification as a Form S-1 registration statement.
2013-11-12 English
FORM 10-Q
Interim / Quarterly Report Q3 2013
2013-11-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.